Monitoring Neonatal Abstinence Syndrome with a wearable device
Official title: Wireless Wearable with AI Analytics for Monitoring Neonatal Abstinence Syndrome (NAS)
Funded at Rekovar INC. · NIH-11039621 · Data updated 2026-11-12
This study is testing a new wearable device called Neomonki that helps doctors keep an eye on newborns with Neonatal Abstinence Syndrome by tracking their symptoms in real-time, making it easier to provide better care for these babies.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rekovar INC. NIH-funded |
| Lab location | 1 site (Lake Forest, UNITED STATES) |
| Project start | February 1, 2025 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $411,800 |
| NIH project number | 1R44DA060640-01A1 |
| Project ID | NIH-11039621 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are newborns aged 0-4 weeks who are diagnosed with Neonatal Abstinence Syndrome due to in utero opioid exposure.
✕Less likely to help
Patients who are not newborns or those who do not have Neonatal Abstinence Syndrome will not benefit from this research.
What this research studies
This research focuses on developing a wearable device called Neomonki that continuously monitors newborns experiencing Neonatal Abstinence Syndrome (NAS). The device uses advanced biosensor technology to track behavioral and physiological symptoms, providing real-time data to healthcare professionals. By utilizing artificial intelligence algorithms, the device aims to improve the accuracy of NAS assessments, reducing the reliance on subjective evaluations. This innovative approach seeks to enhance treatment outcomes and potentially lower the costs associated with NICU care for affected infants.
Why it matters
Potential benefit: If successful, this research could lead to more accurate monitoring and treatment of Neonatal Abstinence Syndrome, improving health outcomes for affected newborns.
How similar studies have gone: Other research has shown promise in using wearable technology for monitoring health conditions, indicating that this approach could be effective for NAS as well.
Where this research is happening
-
Rekovar INC.
Lake Forest, United States Active
Researchers
- Principal investigator: Sharareh, Shiva — Rekovar INC.
- Study coordinator: Sharareh, Shiva
Related research
Other NIH-funded projects on the same topics.
-
A wireless system to monitor opioid withdrawal in newborns.
This study is testing a new wearable device called Neomonki that helps doctors keep an eye on newborns who are going through withdrawal from opioids, making it easier to provide better care and possibly reduce the need for medication and hospital time.
-
Monitoring withdrawal symptoms in newborns exposed to opioids.
This study is working on a new, easy-to-use wireless system that helps doctors keep an eye on babies going through withdrawal from opioids, using comfortable wearable devices to track their heart rate and other signs, so they can provide better care.
-
Monitoring withdrawal symptoms in newborns exposed to opioids.
This study is testing a new, easy-to-use wireless system that helps doctors keep track of withdrawal symptoms in newborns who were exposed to opioids before birth, using comfortable wearable devices to measure things like heart rate and skin responses, so they can provide better care for these babies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.